Asterand Bioscience Awarded Five-Year, $6.5M Contract from the National Institutes of Health (NIH)

Asterand Bioscience has been awarded a five-year, $6.5M contract from the National Institutes of Health (NIH) to provide oncology specimens with associated clinical data to the Clinical Proteomic Tumor Analysis Consortium (CPTAC). Asterand Bioscience has been working with the NIH since 2010 and has provided over 1,500 unique tumor specimens with over 2,500 individual clinical data sets to both The Cancer Genome Atlas (TCGA) Project and CPTAC.

Michael Button, Asterand Bio’s Principal Investigator for both the TCGA and CPTAC project says, “The TCGA and CPTAC projects are creating comprehensive new data sets about the nature of cancer and making them available to researchers globally. The aim is to greatly accelerate the cure for cancer. We are delighted that the NIH recognizes our ability to provide high quality and well annotated tissues with matching biofluids and has elected to extend our partnership.”

“We are delighted to support the NIH in its need for high quality, well annotated oncology tissues,” adds Peter Ferrigno Chief Commercial Office of Asterand Bioscience. “We are confident that the initiatives of the NIH will strengthen the research communities’ ability to find the cures for the cancers that invade us.”